Research Center Jülich, Institute for Neuroscience and Medicine-Neuromodulation INM-7, Jülich, Germany.
Restor Neurol Neurosci. 2012;30(2):137-59. doi: 10.3233/RNN-2012-110218.
Subjective tinnitus is associated with pathologic enhanced neuronal synchronization. We used a model based desynchronization technique, acoustic coordinated reset (CR) neuromodulation, to specifically counteract tinnitus-related neuronal synchrony thereby inducing an unlearning of pathological synaptic connectivity and neuronal synchrony.
In a prospective, randomized, single blind, placebo-controlled trial in 63 patients with chronic tonal tinnitus and up to 50 dB hearing loss we studied safety and efficacy of different doses of acoustic CR neuromodulation. We measured visual analogue scale and tinnitus questionnaire (TQ) scores and spontaneous EEG.
CR treatment was safe, well-tolerated and caused a significant decrease of tinnitus loudness and symptoms. Placebo treatment did not lead to any significant changes. Effects gained in 12 weeks of treatment persisted through a preplanned 4-week therapy pause and showed sustained long-term effects after 10 months of therapy: response, i.e. a reduction of at least 6 TQ points, was obtained in 75% of patients with a mean TQ reduction of 50% among responders. CR therapy significantly lowered tinnitus frequency and reversed the tinnitus related EEG alterations.
The CR-induced reduction of tinnitus and underlying neuronal characteristics indicates a new non-invasive therapy which might also be applicable to other conditions with neuronal hypersynchrony.
主观耳鸣与病理性增强的神经元同步有关。我们使用基于模型的去同步技术,即声协同重置(CR)神经调节,专门对抗与耳鸣相关的神经元同步,从而诱导病理性突触连接和神经元同步的去学习。
在一项针对 63 名患有慢性音调性耳鸣和最高 50 分贝听力损失的患者的前瞻性、随机、单盲、安慰剂对照试验中,我们研究了不同剂量的声 CR 神经调节的安全性和疗效。我们测量了视觉模拟量表和耳鸣问卷(TQ)评分以及自发脑电图。
CR 治疗安全、耐受良好,可显著降低耳鸣响度和症状。安慰剂治疗没有导致任何显著变化。治疗 12 周获得的效果在预先计划的 4 周治疗暂停期间持续,并在治疗 10 个月后显示出持续的长期效果:75%的患者出现反应,即 TQ 至少降低 6 分,其中反应者的 TQ 平均降低 50%。CR 治疗显著降低了耳鸣频率,并逆转了与耳鸣相关的脑电图改变。
CR 诱导的耳鸣减轻和潜在的神经元特征表明了一种新的非侵入性治疗方法,也可能适用于其他具有神经元过度同步的病症。